BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 35411083)

  • 1. Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis.
    Zhang Y; Donaher JL; Das S; Li X; Reinhardt F; Krall JA; Lambert AW; Thiru P; Keys HR; Khan M; Hofree M; Wilson MM; Yedier-Bayram O; Lack NA; Onder TT; Bagci-Onder T; Tyler M; Tirosh I; Regev A; Lees JA; Weinberg RA
    Nat Cell Biol; 2022 Apr; 24(4):554-564. PubMed ID: 35411083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
    Brown MS; Abdollahi B; Wilkins OM; Lu H; Chakraborty P; Ognjenovic NB; Muller KE; Jolly MK; Christensen BC; Hassanpour S; Pattabiraman DR
    Sci Adv; 2022 Aug; 8(31):eabj8002. PubMed ID: 35921406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
    Kröger C; Afeyan A; Mraz J; Eaton EN; Reinhardt F; Khodor YL; Thiru P; Bierie B; Ye X; Burge CB; Weinberg RA
    Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7353-7362. PubMed ID: 30910979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the tumour transition states occurring during EMT.
    Pastushenko I; Brisebarre A; Sifrim A; Fioramonti M; Revenco T; Boumahdi S; Van Keymeulen A; Brown D; Moers V; Lemaire S; De Clercq S; Minguijón E; Balsat C; Sokolow Y; Dubois C; De Cock F; Scozzaro S; Sopena F; Lanas A; D'Haene N; Salmon I; Marine JC; Voet T; Sotiropoulou PA; Blanpain C
    Nature; 2018 Apr; 556(7702):463-468. PubMed ID: 29670281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
    Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
    [No Abstract]   [Full Text] [Related]  

  • 7. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
    Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis.
    Liu X; Li J; Cadilha BL; Markota A; Voigt C; Huang Z; Lin PP; Wang DD; Dai J; Kranz G; Krandick A; Libl D; Zitzelsberger H; Zagorski I; Braselmann H; Pan M; Zhu S; Huang Y; Niedermeyer S; Reichel CA; Uhl B; Briukhovetska D; Suárez J; Kobold S; Gires O; Wang H
    Sci Adv; 2019 Jun; 5(6):eaav4275. PubMed ID: 31223646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms.
    Liao TT; Yang MH
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.
    Cursons J; Leuchowius KJ; Waltham M; Tomaskovic-Crook E; Foroutan M; Bracken CP; Redfern A; Crampin EJ; Street I; Davis MJ; Thompson EW
    Cell Commun Signal; 2015 May; 13():26. PubMed ID: 25975820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.
    Tsai JH; Donaher JL; Murphy DA; Chau S; Yang J
    Cancer Cell; 2012 Dec; 22(6):725-36. PubMed ID: 23201165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.
    Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C
    Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
    Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
    EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
    Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
    Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity.
    Drasin DJ; Robin TP; Ford HL
    Breast Cancer Res; 2011; 13(6):226. PubMed ID: 22078097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
    Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
    J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
    Celià-Terrassa T; Meca-Cortés O; Mateo F; Martínez de Paz A; Rubio N; Arnal-Estapé A; Ell BJ; Bermudo R; Díaz A; Guerra-Rebollo M; Lozano JJ; Estarás C; Ulloa C; Álvarez-Simón D; Milà J; Vilella R; Paciucci R; Martínez-Balbás M; de Herreros AG; Gomis RR; Kang Y; Blanco J; Fernández PL; Thomson TM
    J Clin Invest; 2012 May; 122(5):1849-68. PubMed ID: 22505459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition.
    Latil M; Nassar D; Beck B; Boumahdi S; Wang L; Brisebarre A; Dubois C; Nkusi E; Lenglez S; Checinska A; Vercauteren Drubbel A; Devos M; Declercq W; Yi R; Blanpain C
    Cell Stem Cell; 2017 Feb; 20(2):191-204.e5. PubMed ID: 27889319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.